Table 2.
Study | Failure site | Treatment | n | Median survival (mo) | Survival rate (yr) |
Gwin et al[15], 1993 | Non-hepatic intra-abdominal | R01 | 15 | 25.5 | 60 (2), 0 (3) |
R12 | 6 | 8 | 34 (2), 34 (3) | ||
R23 | 7 | 3.5 | 15 (2) | ||
Shibata et al[13], 2002 | Retroperitoneum | R0 | 15 | 81 | 56 (5) |
R1 | 5 | 29 | 0 (5) | ||
R2 | 4 | 3 | 0 (5) | ||
Bowne et al[14], 2005 | Retroperitoneum | R0 | 8 | 44 | NA |
R1 | 8 | ||||
Min et al[12], 2008 | PALN | R0 | 6 | 34 | 80 (3), 0 (5) |
Chemotherapy4 | 33 | 12 | 18 (3), 7 (5) | ||
Present study | PALN | SBRT | 7 | 41 | 71.4 (3) |
Curative resection;
Marginal resection;
Incomplete, bypass or colostomy;
Resection is not planned. CRC: Colorectal cancer; PALN: Paraaortic lymph node; SBRT: Stereotactic body radiotherapy; NA: Not assessed.